First step to the improvement of the blood brain barrier passage of atazanavir encapsulated in sustainable bioorganic vesicles - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue International Journal of Pharmaceutics Année : 2020

First step to the improvement of the blood brain barrier passage of atazanavir encapsulated in sustainable bioorganic vesicles

Karim El Kirat
Sandrine Morandat

Résumé

The blood - brain barrier (BBB) prevents the majority of therapeutic drugs from reaching the brain following intravenous or oral administration. In this context, polymer nanoparticles are a promising alternative to bypass the BBB and carry drugs to brain cells. Amphiphilic cyclodextrins can form self-assemblies whose nanoparticles have a 100-nm-diameter range and are thus able to encapsulate drugs for controlled release. Our goal is to propose an optimized chemical synthesis of amphiphilic cyclodextrin, which remains a challenging task which commonly leads to only a low-milligram level of the high purity compound. Such cyclodextrin derivatives were used to prepare vesicles and to study their ability to vectorize a drug through the BBB. As a result, we introduced a convergent synthesis for a family of lipophosphoramidyl permethylated β-CDs (Lip-β-CDs) with various chain lengths. It was demonstrated that mixed vesicles comprised of phosphatidylcholine (POPC) and LipCDs were able to encapsulate atazanavir (ATV), a well-known protease inhibitor used as an antiretroviral drug against HIV. We highlighted that neo-vesicles promote the penetration of ATV in endothelial cells of the BBB, presumably due to the low fusogenicity of Lip-β-CDs.
Fichier principal
Vignette du fichier
Open access manuscript.pdf (831.64 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-02980826 , version 1 (09-07-2022)

Identifiants

Citer

Florian Nolay, Emmanuel Sevin, Mathieu Létévé, Abed Bil, Fabien Gosselet, et al.. First step to the improvement of the blood brain barrier passage of atazanavir encapsulated in sustainable bioorganic vesicles. International Journal of Pharmaceutics, 2020, 587, pp.119604. ⟨10.1016/j.ijpharm.2020.119604⟩. ⟨hal-02980826⟩
97 Consultations
40 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More